Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OTHER LIABILITIES
Other Liabilities HALO - Halozyme Therapeutics, Inc.
37.7 M
LAST VALUE
0.00%
2 YEAR CAGR
77.88%
5 YEAR CAGR
-2.08%
10 YEAR CAGR